The Business Times
business-time-50

Medicine

International

Trump’s immigration policy sidelines foreign doctors amid shortage

2026-04-05T22:43:41.000Z
AstraZeneca has made major moves to grow in the US, with a US$50 billion US manufacturing deal in 2025, and a New York Stock Exchange listing this year.
Consumer & Healthcare

AstraZeneca forecasts growth in 2026 as it builds drug pipeline

2026-02-10T09:33:00.000Z
When universities, hospitals and companies work together, innovation bears fruit earlier because real clinical problems guide the design of new solutions.
Opinion & Features
THE BROAD VIEW

Why healthcare innovation must be a team sport

2026-02-06T23:15:00.000Z
The deals include agreements with Eli Lilly and Novo Nordisk to slash the prices of popular GLP-1 weight-loss drugs.
International

Trump unveils TrumpRx discounted drugs website

2026-02-06T02:02:20.000Z
Haw Par's revenue for H1 rose 7 per cent to S$126.3 million, from S$118.1 million a year earlier, as demand for healthcare products remained resilient.
Companies & Markets

Haw Par Corporation H1 net profit up 18.2% at S$144.1 million 

2025-08-12T10:05:30.000Z
White House Press Secretary Karoline Leavitt holds US President Donald Trump's letter to Eli Lilly CEO David Ricks during a press briefing at the White House in Washington, D.C., July 31, 2025.
International

Trump pressures 17 pharma CEOs to cut US drug prices

2025-08-01T00:44:48.000Z
Its traditional Chinese medicine formula, which forms the basis of its product candidates, “contains only natural ingredients without any synthetic components”.
Companies & Markets

Herbal medicine stock with no sales rallies 64,000%

2025-06-17T04:48:51.000Z
YMS’s philosophy is that just as employees contribute to the business, the company must also value-add to their careers.
Singapore
ENTERPRISE 50

Providing caregivers with more than just homecare products

2025-02-19T09:00:00.000Z
Singapore’s strengths position it to ride the precision-medicine wave. The country has deep research and development and clinical expertise, strengths in genomics, and a burgeoning biomedical industry.
Opinion & Features

Singapore has a chance to shine in precision medicine

2024-09-19T21:00:00.000Z
Oxford Nanopore CEO Gordon Sanghera says science breakthroughs can be turned into real-world applications, in areas such as diagnostics and healthcare.
Consumer & Healthcare

Temasek-backed biotech Oxford Nanopore wants to make genetics tech accessible to startups

2024-09-03T06:59:16.000Z
Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More